Affordable Access

deepdyve-link deepdyve-link
Publisher Website

California: 'the Stem Cell State'. Interview with Jonathan Thomas.

Authors
  • Thomas, Jonathan
Type
Published Article
Journal
Regenerative medicine
Publication Date
Nov 01, 2011
Volume
6
Issue
6 Suppl
Pages
113–115
Identifiers
DOI: 10.2217/rme.11.79
PMID: 21999272
Source
Medline
License
Unknown

Abstract

We talked to Jonathan Thomas, newly elected Chairman of the California Institute for Regenerative Medicine (CIRM), a few weeks into a role he describes as "the opportunity of the lifetime" to find out what he sees as the key goals for the CIRM and why patient advocates are so critical to the future of the Institute. Jonathan Thomas was elected as Chairman of the California Institute for Regenerative Medicine (CIRM) in June 2011, succeeding the Founder and former Chairman, Bob Klein. Thomas has had a successful career in finance and law and is a Co-Founding Partner at Saybrook Capital, an investment banking and private equity firm. His commitment to patient advocacy and keen interest in biological sciences, developed as a Biology Major at Yale, led him to stand for Chairman.

Report this publication

Statistics

Seen <100 times